Full Text
Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus- A Cost-Effectiveness Analysis in Canada

Abstract

Authors

S Mursleen JC Gahn RW Klein Y Asukai

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×